ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, will highlight the latest sudden cardiac death research, case experiences for heart failure readmission ...
Presenter: Saman Nazarian, MD, Brigham and Women's Hospital (Boston, Massachusetts) (Dr Nazarian is currently a fellow at Johns Hopkins Hospital in Baltimore, Maryland.) The ultimate cause of death in ...
Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a defibrillator as compared with those who received a defibrillator alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results